Page last updated: 2024-10-24
caffeine and HIV
caffeine has been researched along with HIV in 1 studies
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Enderle, AG | 1 |
| Bosso, M | 1 |
| Groß, R | 1 |
| Heiland, M | 1 |
| Bollini, M | 1 |
| Culzoni, MJ | 1 |
| Kirchhoff, F | 1 |
| Münch, J | 1 |
| Streb, C | 1 |
Other Studies
1 other study available for caffeine and HIV
| Article | Year |
|---|---|
Increased in vitro Anti-HIV Activity of Caffeinium-Functionalized Polyoxometalates.
Topics: Anions; Anti-HIV Agents; Caffeine; Dose-Response Relationship, Drug; HIV; Microbial Sensitivity Test | 2021 |